Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
Journal
Journal of cancer research and therapeutics
ISSN: 1998-4138
Titre abrégé: J Cancer Res Ther
Pays: India
ID NLM: 101249598
Informations de publication
Date de publication:
01 Oct 2023
01 Oct 2023
Historique:
received:
20
02
2021
accepted:
29
04
2022
medline:
20
2
2024
pubmed:
20
2
2024
entrez:
20
2
2024
Statut:
ppublish
Résumé
Last few decades, multiple studies all over the world revealed the association of genetic polymorphism in cytochrome P450 (CYP) genes with risk of developing different type of cancers, but contradictory outcomes were evidenced in case of cervical cancer (CC) risk. Therefore, the discrepancies in earlier reports influenced us to evaluate the association of CYP1A1*2A rs4646903, CYP1B1*3 rs1056836, CYP2C8*2 rs11572103, CYP2C9*2 rs1799853, CYP2C9*3 rs1057910, and CYP2C19*2 rs4244285 polymorphisms and CC susceptibility in the women of rural population of Maharashtra. In this case-control study, genetic association of the polymorphisms in CYP genes was studied by using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method. The study was conducted among 350 clinically confirmed CC patients and 350 healthy volunteers in a population of south-western Maharashtra. The odds ratio (OR) with 95% confidence interval (CI) and P value were evaluated to get the level of association where P ≤ 0.005 was considered as statistically significant. After the analysis of single-nucleotide polymorphism (SNPs) of CYP1A1, CYP1B1, CYP2C8, CYP2C9, and CYP2C19, we noticed that CYP1B1*3 rs1056836 (Leu4326Val) polymorphism possessed a significantly elevated risk (OR = 3.28; 95% CI: 2.18-4.94; P < 0.0001), whereas CYP2C19*2 rs4244285 showed significantly lower risk (OR: 0.53, 95% CI: 0.33-0.85 P < 0.009) of CC in the studied rural population. The findings from this study supported that rs1056836 SNP of CYP1B1*3 increase CC development, whereas rs4244285 of CYP2C19*2 lowers the CC risk in the studied population.
Sections du résumé
BACKGROUND
BACKGROUND
Last few decades, multiple studies all over the world revealed the association of genetic polymorphism in cytochrome P450 (CYP) genes with risk of developing different type of cancers, but contradictory outcomes were evidenced in case of cervical cancer (CC) risk. Therefore, the discrepancies in earlier reports influenced us to evaluate the association of CYP1A1*2A rs4646903, CYP1B1*3 rs1056836, CYP2C8*2 rs11572103, CYP2C9*2 rs1799853, CYP2C9*3 rs1057910, and CYP2C19*2 rs4244285 polymorphisms and CC susceptibility in the women of rural population of Maharashtra.
MATERIALS AND METHODS
METHODS
In this case-control study, genetic association of the polymorphisms in CYP genes was studied by using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method. The study was conducted among 350 clinically confirmed CC patients and 350 healthy volunteers in a population of south-western Maharashtra. The odds ratio (OR) with 95% confidence interval (CI) and P value were evaluated to get the level of association where P ≤ 0.005 was considered as statistically significant.
RESULTS
RESULTS
After the analysis of single-nucleotide polymorphism (SNPs) of CYP1A1, CYP1B1, CYP2C8, CYP2C9, and CYP2C19, we noticed that CYP1B1*3 rs1056836 (Leu4326Val) polymorphism possessed a significantly elevated risk (OR = 3.28; 95% CI: 2.18-4.94; P < 0.0001), whereas CYP2C19*2 rs4244285 showed significantly lower risk (OR: 0.53, 95% CI: 0.33-0.85 P < 0.009) of CC in the studied rural population.
CONCLUSION
CONCLUSIONS
The findings from this study supported that rs1056836 SNP of CYP1B1*3 increase CC development, whereas rs4244285 of CYP2C19*2 lowers the CC risk in the studied population.
Identifiants
pubmed: 38376298
doi: 10.4103/jcrt.jcrt_292_21
pii: 01363817-202319070-00032
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1925-1930Informations de copyright
Copyright © 2023 Copyright: © 2023 Journal of Cancer Research and Therapeutics.
Références
Shrivastava AN, Mishra JS, Shrivastava S, Das BC, Gupta S. Cervical cancer screening in rural India:Status ¤t concepts. Indian J Med Res 2018;148:687–96
Herrero R, Murillo R. Cervical cancer Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D. Cancer Epidemiology and Prevention. 4th ed. New York: Oxford University Press; 2018:925–46
Bag A, Jyala NS, Bag N. Cytochrome P450 1A1 genetic polymorphisms as cancer biomarkers. Indian J Cancer 2015;52:479–89
Elfaki I, Mi R, Almutairi FM, Duhier FMA. Cytochrome P450:Polymorphisms and roles in cancer, diabetes and atherosclerosis. Asian Pac J Cancer Prev 2018;19:2057–70
Wang H, Zhang Z, Han S, Lu Y, Feng F, Yuan J. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility:A meta-analysis from 19 case-control studies. BMC Cancer 2012;12:528
Naif HM, Al-Obaide MAI, Hassani HH, Hamdan AS, Kalaf ZS. Association of Cytochrome CYP1A1 gene polymorphisms and tobacco smoking with the risk of breast cancer in women from Iraq. Front Public Health 2018;6:96
Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer 2009;40:26–32
He X-F, Wei J, Liu Z-Z, Xie J-J, Wang W, Du Y-P, et al. (2014) Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk:A meta-analysis. PLoS One 2014;9:e100487
Bai X, Xie J, Sun S, Zhang X, Jiang Y, Pang D. The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China. Oncotarget 2017;8:38367–77
Yang S, Jia C, Zhu H, Han S. CYP1A1 Ile462Val polymorphism and cervical cancer:Evidence from a meta-analysis. Tumor Biol 2012;33:2265–72
Qin J, Zhang JX, Li XP, Wu BQ, Chen GB, He XF. Association between the CYP1A1 A2455G polymorphism and risk of cancer:Evidence from 272 case-control studies. Tumor Biol 2014;35:3363–76
Zhang H, Li L, Xu Y. CYP1B1 polymorphisms and susceptibility to prostate cancer:A meta-analysis. PLoS One 2013;8:e68634
Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, et al. CYP2B6*6 is associated with increased breast cancer risk. Int J Cancer 2014;134:426–30
Zhou B, Song Z, Qian M, Li L, Gong J, Zou S. Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk:Evidence from 11,042 subjects. PLoS One 2013;8:e66865
Liang S, Hu J, Cao W, Cai S. Correction: Meta-Analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk. PLoS One 2013;8:10.1371/annotation/405a8737-be71-4ff1-8755-a3ccf11cb67f. doi: 10.1371/annotation/405a8737-be71-4ff1-8755-a3ccf11cb67f
doi: 10.1371/annotation/405a8737-be71-4ff1-8755-a3ccf11cb67f
AL-Eitan LN, Rababa'h DM, Alghamdi M, Khasawneh R. Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population. BMC Med Genet 2019;20:148
Altunkol A, Savaş M, Dilmeç F, Utanqac MM, Abat D, Gumuş K, et al. Detection of CYP1A1 and GSTP1 gene polymorphisms in bladder cancer patients in a Turkish population using a polymerase chain reaction-restriction fragment length polymorphism method. Turk J Urol 2018;44:125–31
Ezzeldin N, El-Lebedy D, Darwish A, El-Bastawisy A, Hassan M, El-Aziz SA, et al. Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer. Genes Environ 2017;39:7
Masood N, Malik FA, MahJabeen I, Baig RM, Kayani MA. A novel CYP1A1 gene polymorphism and the risk of head and neck cancer in Pakistani population. Afr J Biotechnol 2011;10:5273–80
Hue H, Lu Y, Xue Z, Lin B, Chen J, Tang F, et al. The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities:A systematic review and meta-analysis. Tumor Biol 2014;35:4741–56
Jorge-Nebert LF, Zang G, Wilson KM, Jiang Z, Bulter R, Gluckman JL, et al. Head-and-neck squamous cell carcinoma risk in smokers:No association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype. Hum Genom 2016;10:39
Economopoulos KP, Sergentanis TN. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk:A meta-analysis. Breast Cancer Res Threat 2010;122:545–51
Gajjar K, Owens G, Sperin M, Martin-Hirsch PL, Martin F. Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk:A meta-analysis. Toxicology 2012;302:157–62
Pandey SN, Choudhuri G, Mittal B. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a north Indian population. Eur J Cancer Prev 2008;17:77–81
Ghoshal U, Tripathi S, Kumar S, Mittal B, Chourasia D, Nirajkumari, et al. Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer 2014;17:226–34
Katiyar T, Maurya SS, Hasan F, Singh AP, Khan AJ, Hadi R, et al. Association of cytochrome P450 1B1 haplotypes with head and neck cancer risk. Environ Mol Mutagen 2017;58:443–50
Srivastava DS, Mandhani A, Mittal RD. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2 A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer:A study from North India. Arch Toxicol 2008;82:633–9
Ding B, Sun W, Han S, Cai Y, Ren M, Shen Y. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk. A systematic review and meta-analysis. Medicine 2018;97:e0210
Wongpratate M, Settheetham-Ishida W, Phuthong S, Natphopsuk S, Ishida T. Genetic polymorphisms of the human cytochrome P450 1A1 (CYP1A1) and cervical cancer susceptibility among Northeast Thai Women. Asian Pac J Cancer Prev 2020;21:243–8
Jain V, Ratre YK, Amle D, Mishra PK, Patra PK. Polymorphism of CYP1A1 gene variants rs4646903 and rs1048943 relation to the incidence of cervical cancer in Chhattisgarh. Environ Toxicol Pharmacol 2017;52:188–92